A patient wearing a simple face mask
Oxygen therapy is the administration of oxygen as a medical intervention, which can be for a variety of purposes in both chronic and acute patient care. Oxygen is essential for cell metabolism, and in turn, tissue oxygenation is essential for all normal physiological functions.
High blood and tissue levels of oxygen can be helpful or damaging, depending on circumstances and oxygen therapy should be used to benefit the patient by increasing the supply of oxygen to the lungs and thereby increasing the availability of oxygen to the body tissues, especially when the patient is suffering from hypoxia and/or hypoxaemia.
- 1 Indications for use
- 2 Storage and sources
- 3 Delivery
- 4 Negative effects
- 5 Oxygen therapy while on aircraft
- 6 See also
- 7 References
- 8 Further reading
Indications for use
Oxygen is used as a medical treatment in both chronic and acute cases, and can be used in hospital, pre-hospital or entirely out of hospital, dependent on the needs of the patient and their medical professionals' opinions.
Use in chronic conditions
A common use of supplementary oxygen is in patients with chronic obstructive pulmonary disease (COPD), the occurrence of chronic bronchitis or emphysema, a common long-term effect of smoking, who may require additional oxygen to breathe either during a temporary worsening of their condition, or throughout the day and night. It is indicated in COPD patients with PaO
2 ≤ 55mmHg (7.3kPa) or SaO
2 ≤ 88% and has been shown to increase lifespan.
Oxygen is often prescribed for people with breathlessness, in the setting of end-stage cardiac or respiratory failure, advanced cancer or neurodegenerative disease, despite having relatively normal blood oxygen levels. A 2010 trial of 239 subjects found no significant difference in reducing breathlessness between oxygen and air delivered in the same way.
Use in acute conditions
It may also be indicated for any other patient where their injury or illness has caused hypoxaemia, although in this case oxygen flow should be moderated to achieve target oxygen saturation levels, based on pulse oximetry (with a target level of 94–98% in most patients, or 88–92% in COPD patients).
Patients who are receiving oxygen therapy for hypoxemia following an acute illness or hospitalization should not routinely have a prescription renewal for continued oxygen therapy without a physician's re-assessment of the patient's condition. If the patient has recovered from the illness, then the hypoxemia is expected to resolve and additional care would be unnecessary and a waste of resources.
Storage and sources
Oxygen can be separated by a number of methods, including chemical reaction and fractional distillation, and then either used immediately or stored for future use. The main types sources for oxygen therapy are:
- Liquid storage — Liquid oxygen is stored in chilled tanks until required, and then allowed to boil (at a temperature of 90.188 K (−182.96 °C)) to release oxygen as a gas. This is widely used at hospitals due to their high usage requirements, but can also be used in other settings. See Vacuum Insulated Evaporator for more information on this method of storage.
- Compressed gas storage — The oxygen gas is compressed in a gas cylinder, which provides a convenient storage, without the requirement for refrigeration found with liquid storage. Large oxygen cylinders hold 6,500 litres (230 cu ft) and can last about two days at a flow rate of 2 litres per minute. A small portable M6 (B) cylinder holds 164 or 170 litres (5.8 or 6.0 cu ft) and weighs about 1.3 to 1.6 kilograms (2.9 to 3.5 lb). These tanks can last 4–6 hours when used with a conserving regulator, which senses the patient's breathing rate and sends pulses of oxygen. Conserving regulators may not be usable by patients who breathe through their mouths.
- Instant usage — The use of an electrically powered oxygen concentrator or a chemical reaction based unit can create sufficient oxygen for a patient to use immediately, and these units (especially the electrically powered versions) are in widespread usage for home oxygen therapy and portable personal oxygen, with the advantage of being continuous supply without the need for additional deliveries of bulky cylinders.
Various devices are used for administration of oxygen. In most cases, the oxygen will first pass through a pressure regulator, used to control the high pressure of oxygen delivered from a cylinder (or other source) to a lower pressure. This lower pressure is then controlled by a flowmeter, which may be preset or selectable, and this controls the flow in a measure such as litres per minute (lpm). The typical flowmeter range for medical oxygen is between 0 and 15 lpm with some units able to obtain up to 25 liters per minute. Many wall flowmeters using a Thorpe tube design are able to be dialed to "flush" which is beneficial in emergency situations.
Many patients require only a supplementary level of oxygen in the room air they are breathing, rather than pure or near pure oxygen, and this can be delivered through a number of devices dependent on the situation, flow required and in some instances patient preference.
A nasal cannula (NC) is a thin tube with two small nozzles that protrude into the patient's nostrils. It can only comfortably provide oxygen at low flow rates, 2–6 litres per minute (LPM), delivering a concentration of 24–40%.
There are also a number of face mask options, such as the simple face mask, often used at between 5 and 8 LPM, with a concentration of oxygen to the patient of between 28% and 50%. This is closely related to the more controlled air-entrainment masks, also known as Venturi masks, which can accurately deliver a predetermined oxygen concentration to the trachea up to 40%.
In some instances, a partial rebreathing mask can be used, which is based on a simple mask, but featuring a reservoir bag, which increases the provided oxygen concentration to 40–70% oxygen at 5 to 15 LPM.
Non-rebreather masks draw oxygen from attached reservoir bags, with one-way valves that direct exhaled air out of the mask. When properly fitted and used at flow rates of 8-10 LPM or higher, they deliver close to 100% oxygen. This type of mask is indicated for acute medical emergencies.
Demand valves or oxygen resuscitators deliver oxygen only when the patient inhales, or, in the case of an apnic (non-breathing) victim, the caregiver presses a button on the mask. These systems greatly conserve oxygen compared to steady-flow masks, which is useful in emergency situations when a limited supply of oxygen is available and there is a delay in transporting the patient to higher care. They are very useful in performing CPR, as the caregiver can deliver rescue breaths composed of 100% oxygen with the press of a button. Care must be taken not to over-inflate the patient's lungs, and some systems employ safety valves to help prevent this. These systems may not be appropriate for unconscious patients or those in respiratory distress, because of the effort required to breathe from them.
High flow oxygen delivery
In cases where the patient requires a high concentration of up to 100% oxygen, a number of devices are available, with the most common being the non-rebreather mask (or reservoir mask), which is similar to the partial rebreathing mask except it has a series of one-way valves preventing exhaled air from returning to the bag. There should be a minimum flow of 10 L/min. The delivered FIO2 of this system is 60-80%, depending on the oxygen flow and breathing pattern. Another type of device is a humidified high flow nasal cannula which enables flows exceeding a patient's peak inspiratory flow demand to be delivered via nasal cannula, thus providing FiO2 of up to 100% because there is no entrainment of room air, even with the mouth open. This also allows the patient to continue to talk, eat and drink while still receiving the therapy. This type of delivery method is associated with greater overall comfort, and improved oxygenation and respiratory rates than with face mask oxygen.
Positive pressure delivery
Patients who are unable to breathe on their own will require positive pressure to move oxygen into their lungs for gaseous exchange to take place. Systems for delivering this vary in complexity (and cost), starting with a basic pocket mask adjunct which can be used by a basically trained first aider to manually deliver artificial respiration with supplemental oxygen delivered through a port in the mask.
Many emergency medical service and first aid personnel, as well as hospitals, will use a bag-valve-mask (BVM), which is a malleable bag attached to a face mask (or invasive airway such as an endotracheal tube or laryngeal mask airway), usually with a reservoir bag attached, which is manually manipulated by the healthcare professional to push oxygen (or air) into the lungs. This is the only procedure allowed for initial treatment of cyanide poisoning in the UK workplace.
Automated versions of the BVM system, known as a resuscitator or pneupac can also deliver measured and timed doses of oxygen direct to patient through a facemask or airway. These systems are related to the anaesthetic machines used in operations under general anaesthesia that allows a variable amount of oxygen to be delivered, along with other gases including air, nitrous oxide and inhalational anaesthetics.
As a drug delivery route
Oxygen and other compressed gasses are used in conjunction with a nebulizer for topical delivery of medications to the upper and lower airways. Nebulizers use compressed gas to propel liquid medication into an aerosol, with specific therapeutically sized droplets, for deposition in the appropriate, desired airway. Compressed gas, usually at flows of 8-10 L/min, is used to "nebulize" medications, saline and sterile water into a theraputeic aerosol for inhalation. In the clinical setting room air (ambient mix of several gasses), Oxygen and Heli-Ox gas are commonly used to nebulize small, large and continuous volumes of liquid.
Filtered oxygen masks
Filtered oxygen masks have the ability to prevent exhaled, potentially infectious particles from being released into the surrounding environment. These masks are normally of a closed design such that leaks are minimized and breathing of room air is controlled through a series of one-way valves. Filtration of exhaled breaths is accomplished either by placing a filter on the exhalation port, or through an integral filter that is part of the mask itself. These masks first became popular in the Toronto (Canada) healthcare community during the 2003 SARS Crisis. SARS was identified as being respiratory based and it was determined that conventional oxygen therapy devices were not designed for the containment of exhaled particles. Common practices of having suspected patients wear a surgical mask was confounded by the use of standard oxygen therapy equipment. In 2003, the HiOx80 oxygen mask was released for sale. The HiOx80 mask is a closed design mask that allows a filter to be placed on the exhalation port. Several new designs have emerged in the global healthcare community for the containment and filtration of potentially infectious particles. Other designs include the ISO-O
2 oxygen mask, the Flo2Max oxygen mask, and the O-Mask. The use of oxygen masks that are capable of filtering exhaled particles is gradually becoming a recommended practice for pandemic preparation in many jurisdictions.
Because filtered oxygen masks use a closed design that minimizes or eliminates inadvertent exposure to room air, delivered oxygen concentrations to the patient have been found to be higher than conventional non-rebreather masks, approaching 99% using adequate oxygen flows. Because all exhaled particles are contained within the mask, nebulized medications are also prevented from being released into the surrounding atmosphere, decreasing the occupational exposure to healthcare staff and other patients.
Intravenous oxygen has been developed and used in humans.
Many EMS protocols indicate that oxygen should not be withheld from any patient, while other protocols are more specific or circumspect. However, there are certain situations in which oxygen therapy is known to have a negative impact on a patient’s condition.
Oxygen should never be given to a patient who is suffering from paraquat poisoning unless they are suffering from severe respiratory distress or respiratory arrest, as this can increase the toxicity. (Paraquat poisoning is rare — for example 200 deaths globally from 1958 to 1978). Oxygen therapy is not recommended for patients who have suffered pulmonary fibrosis or other lung damage resulting from bleomycin treatment.
High levels of oxygen given to infants causes blindness by promoting overgrowth of new blood vessels in the eye obstructing sight. This is retinopathy of prematurity (ROP).
Oxygen has vasoconstrictive effects on the circulatory system, reducing peripheral circulation and was once thought to potentially increase the effects of stroke. However, when additional oxygen is given to the patient, additional oxygen is dissolved in the plasma according to Henry's Law. This allows a compensating change to occur and the dissolved oxygen in plasma supports embarrassed (oxygen-starved) neurons, reduces inflammation and post-stroke cerebral edema. Since 1990, hyperbaric oxygen therapy has been used in the treatments of stroke on a worldwide basis. In rare instances, hyperbaric oxygen therapy patients have had seizures. However, because of the aforementioned Henry's Law effect of extra available dissolved oxygen to neurons, there is usually no negative sequel to the event. Such seizures are generally a result of oxygen toxicity, although hypoglycemia may be a contributing factor, but the latter risk can be eradicated or reduced by carefully monitoring the patient's nutritional intake prior to oxygen treatment.
Oxygen first aid has been used as an emergency treatment for diving injuries for years. Recompression in a hyperbaric chamber with the patient breathing 100% oxygen is the standard hospital and military medical response to decompression illness. The success of recompression therapy as well as a decrease in the number of recompression treatments required has been shown if first aid oxygen is given within four hours after surfacing. There are suggestions that oxygen administration may not be the most effective measure for the treatment of decompression illness and that heliox may be a better alternative.
Chronic obstructive pulmonary disease
Care needs to be exercised in patients with chronic obstructive pulmonary disease, such as emphysema, especially in those known to retain carbon dioxide (type II respiratory failure). Such patients may further accumulate carbon dioxide and decreased pH (hypercapnation) if administered supplemental oxygen, possibly endangering their lives. This is primarily as a result of ventilation–perfusion imbalance (see Effect of oxygen on chronic obstructive pulmonary disease). In the worst case, administration of high levels of oxygen in patients with severe emphysema and high blood carbon dioxide may reduce respiratory drive to the point of precipitating respiratory failure, with an observed increase in mortality compared with those receiving titrated oxygen treatment. However, the risk of the loss of respiratory drive are far outweighed by the risks of withholding emergency oxygen, and therefore emergency administration of oxygen is never contraindicated. Transfer from field care to definitive care, where oxygen use can be carefully calibrated, typically occurs long before significant reductions to the respiratory drive.
A 2010 study has shown that titrated oxygen therapy (controlled administration of oxygen) is less of a danger to COPD patients and that other, non-COPD patients, may also, in some cases, benefit more from titrated therapy.
Highly concentrated sources of oxygen promote rapid combustion. Oxygen itself is not flammable, but the addition of concentrated oxygen to a fire greatly increases its intensity, and can aid the combustion of materials (such as metals) which are relatively inert under normal conditions. Fire and explosion hazards exist when concentrated oxidants and fuels are brought into close proximity; however, an ignition event, such as heat or a spark, is needed to trigger combustion. A well-known example of an accidental fire accelerated by pure oxygen under pressure occurred in the Apollo 1 spacecraft in January 1967 during a ground test; it killed all three astronauts. A similar accident killed Soviet cosmonaut Valentin Bondarenko in 1961.
2 will allow combustion to proceed rapidly and energetically. Steel pipes and storage vessels used to store and transmit both gaseous and liquid oxygen will act as a fuel; and therefore the design and manufacture of O
2 systems requires special training to ensure that ignition sources are minimized. Highly concentrated oxygen in a high-pressure environment can spontaneously ignite hydrocarbons such as oil and grease, resulting in fire or explosion. The heat caused by rapid pressurization serves as the ignition source. For this reason, storage vessels, regulators, piping and any other equipment used with highly concentrated oxygen must be "oxygen-clean" prior to use, to ensure the absence of potential fuels. This does not apply only to pure oxygen; any concentration significantly higher than atmospheric (approximately 21%) carries a potential risk.
Hospitals in some jurisdictions, such as the UK, now operate “no-smoking” policies, which although introduced for other reasons, supports the aim of keeping ignition sources away from medical piped oxygen. Other recorded sources of ignition of medically prescribed oxygen include candles, aromatherapy, medical equipment, cooking, and unfortunately, deliberate vandalism. Smoking pipes, cigars and cigarettes are of special concern. This does not entirely eliminate the risk of injury with portable oxygen systems, especially if compliance is poor.
In alternative medicine
Some practitioners of alternative medicine have promoted "oxygen therapy" as a cure for many human ailments including AIDS, Alzheimer's disease and cancer. The procedure may include injecting hydrogen peroxide, oxygenating blood, or administering oxygen under pressure to the rectum, vagina, or other bodily opening. According to the American Cancer Society, "available scientific evidence does not support claims that putting oxygen-releasing chemicals into a person's body is effective in treating cancer", and some of these treatments can be dangerous.
Oxygen therapy while on aircraft
In the United States, most airlines restrict the devices allowed on board aircraft. As a result passengers are restricted in what devices they can use. Some airlines will provide cylinders for passengers with an associated fee. Other airlines allow passengers to carry on approved portable concentrators. However the lists of approved devices varies by airline so passengers need to check with any airline they are planning to fly on. Passengers are generally not allowed to carry on their own cylinders. In all cases, passengers need to notify the airline in advance of their equipment.
Effective May 13, 2009, the Department of Transportation and FAA ruled that a select number of portable oxygen concentrators are approved for use on all commercial flights.
FAA regulations require larger airplanes to carry D-cylinders of oxygen for use in an emergency.
- Mechanical ventilation
- Hyperbaric oxygen therapy
- Oxygen bar
- Emergency Medical Services
- Respiratory Therapist
- Oxygen tent
- "Clinical Guidelines Update — Oxygen" (PDF). Joint Royal Colleges Ambulance Liaison Committee/Warwick University. April 2009. Retrieved 2009-06-29.
- McDonald, Christine F; Crockett, Alan J; Young, Iven H (2005). "Adult domicilariary oxygen. Position statement of the Thoracic Society of Australia and New Zealand". The Medical Journal of Australia 182 (12): 621–6.
- Stoller, JK.; Panos, RJ.; Krachman, S.; Doherty, DE.; Make, B. (Jul 2010). "Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial.". Chest 138 (1): 179–87. doi:10.1378/chest.09-2555. PMC 2897694. PMID 20605816.
- "Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group.". Ann Intern Med 93 (3): 391–8. Sep 1980. doi:10.7326/0003-4819-93-3-391. PMID 6776858.
- Abernethy, Amy; McDonald, CF; Frith, PA; Clark, K; Herndon, JE 2nd; Marcello, J; Young, IH; Bull, J; Wilcock, A; Booth, S; Wheeler, JL; Tulsky, JA; Crockett, AJ; Currow, DC (4 September 2010). "Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial". Lancet 376 (9743): 784–793. doi:10.1016/S0140-6736(10)61115-4. PMC 2962424. PMID 20816546.
- O'Driscoll BR; Howard LS; Davison AG (October 2008). "BTS guideline for emergency oxygen use in adult patients" (PDF). Thorax (British Thoracic Society) 63 (Suppl 6:vi): 1–68. doi:10.1136/thx.2008.102947. PMID 18838559.
- Sands, George. "Oxygen Therapy for Headaches". Retrieved 2007-11-26.
- American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation (American College of Chest Physicians and American Thoracic Society), retrieved 2013-01-06, which cites
- Croxton, T. L.; Bailey, W. C.; for the NHLBI Working Group on Long-term Oxygen Treatment in COPD (2006). "Long-term Oxygen Treatment in Chronic Obstructive Pulmonary Disease: Recommendations for Future Research". American Journal of Respiratory and Critical Care Medicine 174 (4): 373–378. doi:10.1164/rccm.200507-1161WS. PMC 2648117. PMID 16614349.
- O'Driscoll, B. R.; Howard, L. S.; Davison, A. G.; British Thoracic, S. (2008). "BTS guideline for emergency oxygen use in adult patients". Thorax 63: vi1–v68. doi:10.1136/thx.2008.102947. PMID 18838559.
- MacNee, W. (2005). "Prescription of Oxygen". American Journal of Respiratory and Critical Care Medicine 172 (5): 517–518. doi:10.1164/rccm.2506007. PMID 16120712.
- "Luxfer Aluminum Oxygen Cylinders". CPR Savers & First Aid Supply. Retrieved 2010-04-18.
- McCoy, Robert. "Portable Oxygen Concentrators (POC) Performance Variables that Affect Therapy" (PDF). Retrieved 2007-07-03.
- Evaluation of the System O2 Inc Portable Nonpressurized Oxygen Delivery System
- Kallstrom 2002
- Garcia JA, Gardner D, Vines D, Shelledy D, Wettstein R, Peters J (October 2005). "The Oxygen Concentrations Delivered by Different Oxygen Therapy Systems". Chest Meeting 128 (4): 389S–390S. doi:10.1378/chest.128.4_meetingabstracts.389s-b.
- Earl, John. Delivery of High FiO
2. Cardinal Health Respiratory Abstracts.
- Accurate Oxygen Delivery
- Sim, DA; Dean, P; Kinsella, J; Black, R; Carter, R; Hughes, M (September 2008). "Performance of oxygen delivery devices when the breathing pattern of respiratory failure is simulated.". Anaesthesia 63 (9): 938–40. doi:10.1111/j.1365-2044.2008.05536.x. PMID 18540928.
- Roca O, Riera J, Torres F, Masclans, JR. (April 2010). "High-flow oxygen therapy in acute respiratory failure.". Respiratory Care 55 (4): 408–13. PMID 20406507.
- Cyanide poisoning — New recommendations on first aid treatment
- Hui DS, Hall SD, Chan MT et al. (August 2007). "Exhaled air dispersion during oxygen delivery via a simple oxygen mask". Chest 132 (2): 540–6. doi:10.1378/chest.07-0636. PMID 17573505.
- Mardimae A, Slessarev M, Han J et al. (October 2006). "Modified N95 mask delivers high inspired oxygen concentrations while effectively filtering aerosolized microparticles". Annals of Emergency Medicine 48 (4): 391–9, 399.e1–2. doi:10.1016/j.annemergmed.2006.06.039. PMID 16997675.
- Somogyi R, Vesely AE, Azami T et al. (March 2004). "Dispersal of respiratory droplets with open vs closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome". Chest 125 (3): 1155–7. doi:10.1378/chest.125.3.1155. PMID 15006983.
- Patarinski, D (1976). "Indications and contraindications for oxygen therapy of respiratory insufficiency". Vŭtreshni bolesti (in Bulgarian with English abstract) 15 (4): 44–50. PMID 1007238.
- Experience with paraquat poisoning in a respiratory intensive care unit in North India
- "EMT Medication Formulary" (PDF). PHECC Clinical Practice Guidelines. Pre-Hospital Emergency Care Council. 15 July 2009. p. 84. Retrieved 2010-04-14.
- Smerz, R.W. (2004). "Incidence of oxygen toxicity during the treatment of dysbarism". Undersea and Hyperbaric Medicine 31 (2): 199–202. PMID 15485081. Retrieved 2008-04-30.
- Hampson, Neal B.; Simonson, Steven G.; Kramer, C.C.; Piantadosi, Claude A. (1996). "Central nervous system oxygen toxicity during hyperbaric treatment of patients with carbon monoxide poisoning". Undersea and Hyperbaric Medicine 23 (4): 215–9. PMID 8989851. Retrieved 2008-04-29.
- Brubakk, A. O.; T. S. Neuman (2003). Bennett and Elliott's physiology and medicine of diving, 5th Rev ed. United States: Saunders Ltd. p. 800. ISBN 0-7020-2571-2.
- Undersea and Hyperbaric Medical Society. "Decompression Sickness or Illness and Arterial Gas Embolism". Retrieved 2008-05-30.
- Acott, C. (1999). "A brief history of diving and decompression illness". South Pacific Underwater Medicine Society Journal 29 (2). ISSN 0813-1988. OCLC 16986801. Retrieved 2008-05-30.
- Longphre, J. M.; P. J. DeNoble; R. E. Moon; R. D. Vann; J. J. Freiberger (2007). "First aid normobaric oxygen for the treatment of recreational diving injuries". Undersea Hyperb Med. 34 (1): 43–49. ISSN 1066-2936. OCLC 26915585. PMID 17393938. Retrieved 2008-05-30.
- Kol S, Adir Y, Gordon CR, Melamed Y (June 1993). "Oxy-helium treatment of severe spinal decompression sickness after air diving". Undersea Hyperb Med 20 (2): 147–54. PMID 8329941. Retrieved 2008-05-30.
- Austin, Michael A; Wills, Karen E; Blizzard, Leigh; Walters, Eugene H; Wood-Baker, Richard (18 October 2010). "Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial". British Medical Journal 341 (oct18 2): c5462. doi:10.1136/bmj.c5462. ISSN 0959-8138. PMC 2957540. PMID 20959284.
- Kim, Victor; Benditt, Joshua O; Wise, Robert A; Sharafkhaneh, Amir (2008). "Oxygen therapy in chronic obstructive pulmonary disease". Proceedings of the American Thoracic Society 5 (4): 513–8. doi:10.1513/pats.200708-124ET. PMC 2645328. PMID 18453364.
- Werley, Barry L. (Edtr.) (1991). "Fire Hazards in Oxygen Systems". ASTM Technical Professional training. Philadelphia: ASTM International Subcommittee G-4.05.
- Lindford AJ, Tehrani H, Sassoon EM, O'Neill TJ (June 2006). "Home Oxygen Therapy and Cigarette Smoking: A Dangerous Practice". Annals of Burns and Fire Disasters 19 (2).
- "Oxygen Therapy". American Cancer Society. 26 December 2012. Retrieved 2013-09-20.
- "FAA Approved Portable Oxygen Concentrators - Positive Testing Results". faa.gov. Retrieved 2014-06-22.
(As of November 2014[update]) Positive Testing Results: AirSep FreeStyle, AirSep LifeStyle, AirSep Focus, AirSep Freestyle 5, (Caire) SeQual eQuinox / Oxywell (model 4000), Delphi RS-00400 / Oxus RS-00400, DeVilbiss Healthcare iGo, Inogen One, Inogen One G2, lnogen One G3, lnova Labs LifeChoice Activox, International Biophysics LifeChoice / lnova Labs LifeChoice, Invacare XPO2, Invacare Solo 2, Oxylife Independence Oxygen Concentrator , Precision Medical EasyPulse, Respironics EverGo, Respironics SimplyGo, Sequal Eclipse, SeQual SAROS, VBox Trooper
- Kallstrom, TJ (June 2002). "American Association for Respiratory Care Clinical Practice Guideline: Oxygen therapy for adults in the acute care facility—2002 Revision & Update". Respir Care 47 (6): 717–20. PMID 12078655.
- Cahill Lambert AE (November 2005). "Adult domiciliary oxygen therapy: a patient's perspective". The Medical Journal of Australia 183 (9): 472–3. PMID 16274348.